62 participants
Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2005-06-24
- Start Date:
- 2001-12-31
Conditions
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
Interventions
- DRUG
No Results Yet